David Koos
Chief Executive Officer chez REGEN BIOPHARMA, INC.
Fortune : 336 631 $ au 31/03/2024
Profil
David Raymond Koos was the founder of Entest Group, Inc. (founded in 2008) where he held the titles of Chairman, President, CEO, CFO & Secretary from 2009 to 2018.
He is currently the Chairman, President, CEO, Secretary & Treasurer at Kcl Therapeutics, Inc. (since 2021), Chairman & Chief Executive Officer at BST Partners, Inc. (since 2018), Chairman, Chief Executive & Financial Officer at Regen Biopharma, Inc. (since 2012), President & Managing Director at Venture Bridge, Inc. (since 2001), President, Managing Director & Director at Cell Source Research, Inc. (since 2003), and a Trustee at BMXP Holdings Shareholders Business Trust and AFN Trust.
In his former positions, Dr. Koos served as President & Chief Executive Officer at Tasco Holdings International, Inc. in 2006, Chairman, Chief Executive Officer, CFO & Secretary at Frezer, Inc. from 2005 to 2007, President, CEO, CFO, Secretary & CAO at JB Clothing Corp.
in 2009, Chairman, CEO & Acting Chief Financial Officer at BMXP Holdings, Inc. from 2004 to 2008, Chairman, President, CEO, CFO & Secretary at Rivulet Media, Inc. from 2006 to 2019, and Chairman & Chief Executive Officer at Zander Therapeutics, Inc. from 2015 to 2020.
He also held positions at Freedom Environmental Services, Inc., BEFUT International Co. Ltd., Entest BioMedical, Inc., BST Partners, Inc. (Wyoming), and Cell Bio-Systems, Inc.Dr. Koos obtained a graduate degree from the University of California, Riverside in 1983 and a doctorate degree from Atlantic International University in 2003.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/11/2023 | 122 221 ( 29,84% ) | 318 997 $ | 31/03/2024 | |
REGEN BIOPHARMA INC PFD SER NC
100,00% | 06/11/2023 | 15 007 ( 100,00% ) | 11 255 $ | 31/03/2024 |
REGEN BIOPHARMA, INC.
0,02% | 06/11/2023 | 7 667 ( 0,02% ) | 5 750 $ | 31/03/2024 |
REGEN BIOPHARMA, INC.
0,01% | 06/11/2023 | 504 ( 0,01% ) | 378 $ | 31/03/2024 |
REGEN BIOPHARMA, INC.
0,67% | 06/11/2023 | 334 ( 0,67% ) | 251 $ | 31/03/2024 |
Postes actifs de David Koos
| Sociétés | Poste | Début |
|---|---|---|
| REGEN BIOPHARMA, INC. | Chief Executive Officer | 24/04/2012 |
| BST Partners, Inc. | Chief Executive Officer | 30/11/2018 |
| Kcl Therapeutics, Inc. | Chief Executive Officer | 23/03/2021 |
| AFN Trust | Director/Board Member | - |
| BMXP Holdings Shareholders Business Trust | Director/Board Member | - |
| Cell Source Research, Inc. | Chief Executive Officer | 24/03/2003 |
| Venture Bridge, Inc. | Chief Executive Officer | 21/11/2001 |
Anciens postes connus de David Koos
| Sociétés | Poste | Fin |
|---|---|---|
| SYBLEU INC. | Chief Executive Officer | 13/12/2022 |
Zander Therapeutics, Inc.
 Zander Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zander Therapeutics, Inc. engages in the development and commercialization of veterinary medical therapies. It focuses on developing small molecule immunotherapies and cancer stem cell therapies for the veterinary market. The company was founded on July 18, 2015 and is headquartered in La Mesa, CA. | Chief Executive Officer | 22/01/2020 |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de David Koos
| University of California, Riverside | Graduate Degree |
| Atlantic International University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| REGEN BIOPHARMA, INC. | Health Technology |
| RIVULET MEDIA, INC. | Technology Services |
| ENTEST GROUP, INC. | Finance |
| SYBLEU INC. | Commercial Services |
| Entreprise privées | 16 |
|---|---|
Cell Bio-Systems, Inc.
 Cell Bio-Systems, Inc. Medical SpecialtiesHealth Technology Cell Bio-Systems, Inc. developed medical devices and patented technologies for the living tissue markets, including plastic, cosmetic, and orthopedic surgeries. The company was headquartered in San Diego, CA. | Health Technology |
| Tasco Holdings International, Inc. | Finance |
Frezer, Inc.
 Frezer, Inc. Medical SpecialtiesHealth Technology The Company's principal activity is to develop medical devices. The Company develops Cryogenic Stem Cell Banks. Stem cell banking provides the patient the necessary building blocks for future regenerative medical treatments. Regenerative Medicine helps in finding treatments for diabetes, Parkinson's disease and other degenerative diseases. The Company is in development stage. | Health Technology |
| BMXP Holdings Shareholders Business Trust | |
JB Clothing Corp.
 JB Clothing Corp. Apparel/Footwear RetailRetail Trade JB Clothing Corp. designs and manufactures women's fashion apparels. It manufactures and markets shorts, tops, Tees, and hats. It was founded on September 24, 2008 and is headquartered in Las Vegas, NV. | Retail Trade |
Freedom Environmental Services, Inc.
 Freedom Environmental Services, Inc. Miscellaneous Commercial ServicesCommercial Services Freedom Environmental Services, Inc. provided waste water and storm-water system management, grease and organics collection and disposition, and commercial plumbing and water system management to the commercial and industrial customers. The company was founded on October 6, 1978 and is headquartered in Orlando, FL. | Commercial Services |
| BEFUT International Co. Ltd. /Old/ | Producer Manufacturing |
| Entest BioMedical, Inc. /Old/ | Health Technology |
| Venture Bridge, Inc. | |
| Cell Source Research, Inc. | |
| AFN Trust | |
Zander Therapeutics, Inc.
Zander Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zander Therapeutics, Inc. engages in the development and commercialization of veterinary medical therapies. It focuses on developing small molecule immunotherapies and cancer stem cell therapies for the veterinary market. The company was founded on July 18, 2015 and is headquartered in La Mesa, CA. | Health Technology |
| Kcl Therapeutics, Inc. | |
| BST Partners, Inc. | |
| BST Partners, Inc. (Wyoming) | |
| BMXP Holdings, Inc. | Health Technology |
